Ipca Laboratories Limited (NSE:IPCALAB)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceuticals	96.46B	89.41B	77.06B	62.48B	58.31B
Pharmaceuticals Growth	7.89%	16.03%	23.33%	7.16%	7.56%
Total	96.46B	89.41B	77.06B	62.48B	58.31B
Total Growth	7.89%	16.03%	23.33%	7.16%	7.56%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	43.87B	40.42B	36.14B	32.65B	30.11B
India Growth	8.53%	11.84%	10.68%	8.44%	22.56%
outside India	52.60B	48.98B	40.91B	29.79B	28.19B
outside India Growth	7.39%	19.72%	37.33%	5.69%	-4.88%
Total	96.46B	89.40B	77.05B	62.44B	58.30B
Total Growth	7.91%	16.02%	23.39%	7.11%	7.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error